Vitrolife AB (publ) (VTRLY)
USD 18.0
(7.46%)
USD 18.0
(7.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.87 Billion SEK | -8.22% |
| 2022 | 2.04 Billion SEK | 0.8% |
| 2021 | 2.02 Billion SEK | 4052.47% |
| 2020 | 48.81 Million SEK | -20.26% |
| 2019 | 61.21 Million SEK | 0.0% |
| 2018 | - SEK | -100.0% |
| 2017 | 399 Thousand SEK | -14.38% |
| 2016 | 466 Thousand SEK | -98.69% |
| 2015 | 35.62 Million SEK | -40.64% |
| 2014 | 60.01 Million SEK | 177.58% |
| 2013 | 21.62 Million SEK | -62.87% |
| 2012 | 58.22 Million SEK | -5.39% |
| 2011 | 61.54 Million SEK | 93.71% |
| 2010 | 31.77 Million SEK | 341.69% |
| 2009 | 7.19 Million SEK | 116.59% |
| 2008 | 3.32 Million SEK | -76.78% |
| 2007 | 14.3 Million SEK | 0.0% |
| 2006 | - SEK | 0.0% |
| 2005 | - SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 1.8 Billion SEK | -3.47% |
| 2024 Q2 | 1.87 Billion SEK | -1.0% |
| 2024 Q1 | 1.89 Billion SEK | 0.85% |
| 2023 Q4 | 1.87 Billion SEK | -6.76% |
| 2023 Q2 | 2.12 Billion SEK | 5.88% |
| 2023 Q1 | 2 Billion SEK | -1.76% |
| 2023 FY | 1.87 Billion SEK | -8.22% |
| 2023 Q3 | 2.01 Billion SEK | -5.36% |
| 2022 Q3 | 2 Billion SEK | -1.42% |
| 2022 Q2 | 2.03 Billion SEK | 2.77% |
| 2022 Q4 | 2.04 Billion SEK | 1.69% |
| 2022 FY | 2.04 Billion SEK | 0.8% |
| 2022 Q1 | 1.98 Billion SEK | -2.16% |
| 2021 Q1 | 46.74 Million SEK | -4.23% |
| 2021 FY | 2.02 Billion SEK | 4052.47% |
| 2021 Q3 | 52.6 Million SEK | -5.85% |
| 2021 Q4 | 2.02 Billion SEK | 3752.61% |
| 2021 Q2 | 55.88 Million SEK | 19.55% |
| 2020 Q1 | 59.28 Million SEK | -3.15% |
| 2020 Q4 | 48.81 Million SEK | -6.46% |
| 2020 Q3 | 52.18 Million SEK | -6.64% |
| 2020 FY | 48.81 Million SEK | -20.26% |
| 2020 Q2 | 55.89 Million SEK | -5.73% |
| 2019 Q3 | 64.33 Million SEK | -2.79% |
| 2019 FY | 61.21 Million SEK | 0.0% |
| 2019 Q1 | 66.19 Million SEK | 0.0% |
| 2019 Q4 | 61.21 Million SEK | -4.86% |
| 2019 Q2 | 66.18 Million SEK | -0.02% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q1 | 396 Thousand SEK | -0.75% |
| 2018 FY | - SEK | -100.0% |
| 2018 Q2 | - SEK | -100.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2017 Q4 | 399 Thousand SEK | -1.97% |
| 2017 FY | 399 Thousand SEK | -14.38% |
| 2017 Q3 | 407 Thousand SEK | -5.79% |
| 2017 Q2 | 432 Thousand SEK | -3.14% |
| 2017 Q1 | 446 Thousand SEK | -4.29% |
| 2016 Q4 | 466 Thousand SEK | -98.37% |
| 2016 Q1 | 33 Million SEK | -7.36% |
| 2016 Q2 | 31.1 Million SEK | -5.77% |
| 2016 FY | 466 Thousand SEK | -98.69% |
| 2016 Q3 | 28.66 Million SEK | -7.84% |
| 2015 Q2 | 48.85 Million SEK | -8.91% |
| 2015 Q1 | 53.63 Million SEK | -10.64% |
| 2015 Q4 | 35.62 Million SEK | -10.41% |
| 2015 FY | 35.62 Million SEK | -40.64% |
| 2015 Q3 | 39.76 Million SEK | -18.6% |
| 2014 Q3 | 11.01 Million SEK | -20.92% |
| 2014 Q1 | 17.58 Million SEK | -18.66% |
| 2014 FY | 60.01 Million SEK | 177.58% |
| 2014 Q4 | 60.01 Million SEK | 444.74% |
| 2014 Q2 | 13.93 Million SEK | -20.78% |
| 2013 Q4 | 21.62 Million SEK | -29.34% |
| 2013 Q2 | 47.86 Million SEK | -3.27% |
| 2013 Q3 | 30.59 Million SEK | -36.07% |
| 2013 Q1 | 49.47 Million SEK | -15.03% |
| 2013 FY | 21.62 Million SEK | -62.87% |
| 2012 Q3 | 49.23 Million SEK | -8.75% |
| 2012 Q1 | 52.76 Million SEK | -14.27% |
| 2012 Q2 | 53.95 Million SEK | 2.26% |
| 2012 Q4 | 58.22 Million SEK | 18.28% |
| 2012 FY | 58.22 Million SEK | -5.39% |
| 2011 FY | 61.54 Million SEK | 93.71% |
| 2011 Q4 | 61.54 Million SEK | 110.28% |
| 2011 Q2 | 28.97 Million SEK | -10.82% |
| 2011 Q1 | 32.49 Million SEK | 2.28% |
| 2011 Q3 | 29.26 Million SEK | 1.0% |
| 2010 Q3 | 2.71 Million SEK | -17.65% |
| 2010 FY | 31.77 Million SEK | 341.69% |
| 2010 Q2 | 3.29 Million SEK | 0.0% |
| 2010 Q4 | 31.77 Million SEK | 1071.93% |
| 2009 Q4 | 7.19 Million SEK | 0.0% |
| 2009 FY | 7.19 Million SEK | 116.59% |
| 2008 FY | 3.32 Million SEK | -76.78% |
| 2007 FY | 14.3 Million SEK | 0.0% |
| 2006 FY | - SEK | 0.0% |
| 2005 FY | - SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| IR-Med Inc. | 161 Thousand USD | -1164496.273% |
| Polarean Imaging plc | 74.84 Thousand USD | -2505043.895% |
| Avitar, Inc. | 3.89 Million USD | -48020.701% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -1615527.208% |
| CVR Medical Corp. | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -417045.921% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | -501.343% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | -9840.844% |
| Össur hf. | 311.8 Million USD | -501.343% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -303298.058% |
| Escalon Medical Corp. | 279.4 Thousand USD | -670971.28% |
| Aurora Spine Corporation | 1.59 Million USD | -117690.218% |
| BrainsWay Ltd. | 239 Thousand USD | -784418.828% |
| BioElectronics Corporation | 12.52 Million USD | -14864.527% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | -11123.612% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | -130.284% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -861529.237% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -4292875.547% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -317696.61% |
| Nanomix Corporation | 10.11 Million USD | -18443.314% |
| Theraclion SA | 1.95 Million EUR | -96017.568% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -615461.392% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -1249900.0% |
| Lombard Medical, Inc. | 28.02 Million USD | -6590.455% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | -2000.706% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -770594.694% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -1317270.318% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -380997.561% |
| VMS Rehab Systems, Inc. | 106.45 USD | -1761390224.096% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -366827.593% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -352160.857% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | -233108.955% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -581472.075% |
| Urologix, Inc. | 4.58 Million USD | -40785.303% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -435708.337% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -67192.843% |
| SS Innovations International, Inc. | 1.91 Million USD | -98045.341% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 13.671% |
| NIOX Group Plc | 500 Thousand USD | -374900.0% |
| Fuse Medical, Inc. | 200 Thousand USD | -937400.0% |
| Broncus Holding Corporation | 1.22 Million USD | -153086.275% |
| Brain Scientific Inc. | 7378.00 USD | -25413291.163% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -1158279.874% |
| Health Logic Interactive Inc. | - USD | -Infinity% |